NATERA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NATERA, INC. (NTRA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 10.93 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 11.90M shares, a 14.37% decline year-over-year.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.89M shares, a 42.69% decline year-over-year.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 24.24M shares, a 3.55% increase year-over-year.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 23.41M shares, a 9.28% increase year-over-year.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 12.46M shares, a 14.08% decline from fiscal 2024.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 14.51M shares, a 34.79% decline from fiscal 2023.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 22.25M shares, a 11.25% increase from fiscal 2022.
- NATERA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 20.00M shares, a 13.09% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 10.93M shares 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | 11.90M shares 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | 12.46M shares 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | 12.72M shares 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 13.34M shares 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | 13.89M shares 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | 14.51M shares 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | 22.54M shares 10-Q · filed 2025-11-07 | ||||
| 2024-06-30 | 23.21M shares 10-Q · filed 2025-08-08 | ||||
| 2024-03-31 | 24.24M shares 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | 22.25M shares 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | 22.57M shares 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | 22.57M shares 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | 23.41M shares 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | 20.00M shares 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | 20.67M shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 21.49M shares 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | 21.42M shares 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | 17.68M shares 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | 17.55M shares 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 17.72M shares 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | 18.42M shares 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | 18.34M shares 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | 18.70M shares 10-Q · filed 2021-11-05 | ||||
| 2020-06-30 | 19.34M shares 10-Q · filed 2021-08-06 | ||||
| 2020-03-31 | 12.72M shares 10-Q · filed 2021-05-07 | ||||
| 2019-12-31 | 10.93M shares 10-K · filed 2022-02-25 | 10.93K shares 10-K · filed 2020-03-02 | |||
| 2019-09-30 | 11.19M shares 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | 11.79M shares 10-Q · filed 2020-08-07 | ||||
| 2019-03-31 | 11.72M shares 10-Q · filed 2020-05-08 | ||||
| 2018-12-31 | 10.59M shares 10-K · filed 2021-02-26 | 10.59K shares 10-K · filed 2019-03-15 | |||
| 2018-09-30 | 10.38M shares 10-Q · filed 2019-11-08 | ||||
| 2018-06-30 | 11.35M shares 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | 12.30M shares 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | 10.43K shares 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | 10.92M shares 10-Q · filed 2018-11-09 | ||||
| 2017-06-30 | 10.80M shares 10-Q · filed 2018-08-09 | ||||
| 2017-03-31 | 9.12M shares 10-Q · filed 2018-05-10 | ||||
| 2016-12-31 | 9.67K shares 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | 9.84M shares 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | 9.79M shares 10-Q · filed 2016-08-11 | 10.05M shares 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | 8.77M shares 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | 11.00K shares 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | 11.21M shares 10-Q · filed 2015-11-13 | 11.21M shares 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | 43.14M shares 10-Q · filed 2016-08-11 | 43.14M shares 10-Q · filed 2015-08-13 | |||
| 2015-03-31 | 43.20M shares 10-Q · filed 2016-05-13 | ||||
| 2014-12-31 | 42.40K shares 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | 5.11M shares 10-Q · filed 2015-11-13 | 37.17M shares 10-Q · filed 2015-11-13 | |||
| 2014-06-30 | 36.00M shares 10-Q · filed 2015-08-13 | ||||
| 2013-12-31 | 33.94K shares 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |